These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 14728523)
1. Prescription of amiodarone through a computerized template that includes both decision support and executive functions improves the monitoring for toxicities. Stewart K; Loftus S; DeLisle S AMIA Annu Symp Proc; 2003; 2003():1020. PubMed ID: 14728523 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of a pharmacist-managed amiodarone monitoring program. Spence MM; Polzin JK; Weisberger CL; Martin JP; Rho JP; Willick GH J Manag Care Pharm; 2011 Sep; 17(7):513-22. PubMed ID: 21870892 [TBL] [Abstract][Full Text] [Related]
3. Adherence to the NASPE guideline for amiodarone monitoring at a medical university. Bickford CL; Spencer AP J Manag Care Pharm; 2006 Apr; 12(3):254-9. PubMed ID: 16623610 [TBL] [Abstract][Full Text] [Related]
4. [Medication control monitoring in amiodarone therapy. What is essential?]. Füessl HS; Stiefelhagen P MMW Fortschr Med; 2014 May; 156(9):17. PubMed ID: 24908872 [No Abstract] [Full Text] [Related]
5. Results of a safety initiative for patients on concomitant amiodarone and simvastatin therapy in a Veterans Affairs medical center. Karimi S; Hough A; Beckey C; Parra D J Manag Care Pharm; 2010 Sep; 16(7):472-81. PubMed ID: 20726676 [TBL] [Abstract][Full Text] [Related]
6. Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review. Snider M; Kalbfleisch S; Carnes CA Clin Ther; 2009 Jun; 31(6):1209-18. PubMed ID: 19695388 [TBL] [Abstract][Full Text] [Related]
7. What internists should know about amiodarone. Murphy MT; Wilkoff BL Cleve Clin J Med; 1998 Mar; 65(3):159-66. PubMed ID: 9540249 [TBL] [Abstract][Full Text] [Related]
8. Monitoring the use of amiodarone: compliance with guidelines. Burgess C; Blaikie A; Ingham T; Robinson G; Narasimhan S Intern Med J; 2006 May; 36(5):289-93. PubMed ID: 16650193 [TBL] [Abstract][Full Text] [Related]
9. Optimal management of amiodarone therapy: efficacy and side effects. Hilleman D; Miller MA; Parker R; Doering P; Pieper JA Pharmacotherapy; 1998; 18(6 Pt 2):138S-145S. PubMed ID: 9855346 [TBL] [Abstract][Full Text] [Related]
11. Time-frequency analysis of the surface electrocardiogram for monitoring antiarrhythmic drug effects in atrial fibrillation. Husser D; Stridh M; Sornmo L; Geller C; Klein HU; Olsson SB; Bollmann A Am J Cardiol; 2005 Feb; 95(4):526-8. PubMed ID: 15695146 [TBL] [Abstract][Full Text] [Related]
13. Dronedarone-induced digoxin toxicity: new drug, new interactions. Vallakati A; Chandra PA; Pednekar M; Frankel R; Shani J Am J Ther; 2013; 20(6):e717-9. PubMed ID: 21519214 [TBL] [Abstract][Full Text] [Related]
14. Adherence to amiodarone monitoring recommendations before and after implementation of a centralized pharmacy service: a cohort study. Johnson SG; Canty K; Billups S; Schimmer J J Pharm Pract; 2010 Dec; 23(6):536-9. PubMed ID: 21507859 [TBL] [Abstract][Full Text] [Related]
15. Amiodarone monitoring practices in pediatric hospitals in the United States. Moffett BS; Valdes SO; Kim JJ Pediatr Cardiol; 2013; 34(8):1762-6. PubMed ID: 23640245 [TBL] [Abstract][Full Text] [Related]
16. Can amiodarone be restarted after amiodarone-induced thyrotoxicosis? Ryan LE; Braverman LE; Cooper DS; Ladenson PW; Kloos RT Thyroid; 2004 Feb; 14(2):149-53. PubMed ID: 15068630 [TBL] [Abstract][Full Text] [Related]